Enumeration and characterization of human memory t cells by enzyme-linked immunospot assays

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Calarota, Sandra A ^a   Baldanti, Fausto ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LAMIVUDINE; VACCINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CYTOKINE PRODUCTION; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; LYMPHOCYTE CULTURE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS LOAD; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; METHODOLOGY; T LYMPHOCYTE SUBPOPULATION;

ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; T-LYMPHOCYTE SUBSETS;

EID: 84890046091     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/637649     Document Type: Review

References (53)

1. Czerkinsky C. C., Nilsson L. A., Nygren H., A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. Journal of Immunological Methods 1983 65 1-2 109 121 2-s2.0-0021020342 (Pubitemid 14203438)
2. Czerkinsky C., Andersson G., Ekre H.-P., Nilsson L.-A., Klareskog L., Ouchterlony O., Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secretion cells. Journal of Immunological Methods 1988 110 1 29 36 2-s2.0-0023945701 10.1016/0022-1759(88) 90079-8
3. Lehmann P. V., Zhang W., Unique strengths of ELISPOT for T cell diagnostics. Methods in Molecular Biology 2012 792 3 23 2-s2.0-80555139568 10.1007/978-1-61779-325-7-1
4. Cox J. H., Ferrari G., Kalams S. A., Lopaczynski W., Oden N., D'Souza M. P., Cao H., McNicholl J., Koup R., Gray C., Horton H., Pantaleo G., Gillmour J., Bernard N., Hudgens M., Janetzki S., Lehmann P., Tary-Lehmann M., Cosentino M., Turk E., Hedgepeth A., Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Research and Human Retroviruses 2005 21 1 68 81 2-s2.0-19944431341 10.1089/aid.2005.21.68 (Pubitemid 40179803)
5. Zhang W., Caspell R., Karulin A. Y., Ahmad M., Haicheur N., Abdelsalam A., Johannesen K., Vignard V., Dudzik P., Georgakopoulou K., Mihaylova A., Silina K., Aptsiauri N., Adams V., Lehmann P. V., McArdle S., ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring-even in hands of ELISPOT-inexperienced investigators. Journal of Immunotoxicology 2009 6 4 227 234 2-s2.0-70450211340 10.3109/15476910903317546
6. Boaz M. J., Hayes P., Tarragona T., Seamons L., Cooper A., Birungi J., Kitandwe P., Semaganda A., Kaleebu P., Stevens G., Anzala O., Farah B., Ogola S., Indangasi J., Mhlanga P., Van Eeden M., Thakar M., Pujari A., Mishra S., Goonetilleke N., Moore S., Mahmoud A., Sathyamoorthy P., Mahalingam J., Narayanan P. R., Ramanathan V. D., Cox J. H., Dally L., Gill D. K., Gilmour J., Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents. Clinical and Vaccine Immunology 2009 16 2 147 155 2-s2.0-59649110914 10.1128/CVI.00326-08
7. Schroder K., Hertzog P. J., Ravasi T., Hume D. A., Interferon- γ: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology 2004 75 2 163 189 2-s2.0-0842266786 10.1189/jlb.0603252 (Pubitemid 38174573)
8. Malyguine A., Strobl S., Zaritskaya L., Baseler M., Shafer-Weaver K., New approaches for monitoring CTL activity in clinical trials. Advances in Experimental Medicine and Biology 2007 601 273 284 2-s2.0-34848855542 10.1007/978-0-387-72005-0-29
9. Boulet S., Ndongala M. L., Peretz Y., Boisvert M.-P., Boulassel M.-R., Tremblay C., Routy J.-P., Sekaly R.-P., Bernard N. F., A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN- γ HIV-specific immune responses. Journal of Immunological Methods 2007 320 1-2 18 29 2-s2.0-33847380680 10.1016/j.jim.2006.11.010 (Pubitemid 46349097)
10. Ahlborg N., Axelsson B., Dual-and triple-color fluorospot. Methods in Molecular Biology 2012 792 77 85 2-s2.0-80555153902 10.1007/978-1-61779-325-7-6
11. Rebhahn J. A., Bishop C., Divekar A. A., Jiminez-Garcia K., Kobie J. J., Lee F. E.-H., Maupin G. M., Snyder-Cappione J. E., Zaiss D. M., Mosmann T. R., Automated analysis of two- and three-color fluorescent Elispot (Fluorospot) assays for cytokine secretion. Computer Methods and Programs in Biomedicine 2008 92 1 54 65 2-s2.0-49949106240 10.1016/j.cmpb.2008.06.002
12. Kaech S. M., Wherry E. J., Ahmed R., Effector and memory T-cell differentiation: implications for vaccine development. Nature Reviews Immunology 2002 2 4 251 262 2-s2.0-0036550559 (Pubitemid 37323225)
13. Hammarlund E., Lewis M. W., Hansen S. G., Strelow L. I., Nelson J. A., Sexton G. J., Hanifin J. M., Slifka M. K., Duration of antiviral immunity after smallpox vaccination. Nature Medicine 2003 9 9 1131 1137 2-s2.0-0141796316 10.1038/nm917 (Pubitemid 37173696)
14. Amara R. R., Nigam P., Sharma S., Liu J., Bostik V., Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. Journal of Virology 2004 78 8 3811 3816 2-s2.0-1842432621 10.1128/JVI.78.8.3811- 3816.2004 (Pubitemid 38437186)
15. Sallusto F., Geginat J., Lanzavecchia A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual Review of Immunology 2004 22 745 763 2-s2.0-2142730100 10.1146/annurev.immunol.22.012703. 104702 (Pubitemid 38680440)
16. + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. Journal of Immunological Methods 2003 278 1-2 79 93 2-s2.0-0142071152 10.1016/S0022-1759(03)00226-6 (Pubitemid 37281194)
17. Minang J. T., Areström I., Ahlborg N., ELISpot displays a better detection over ELISA of T helper (Th) 2-type cytokine-production by ex vivo-stimulated antigen-specific T cells from human peripheral blood. Immunological Investigations 2008 37 4 279 291 2-s2.0-45949087621 10.1080/08820130802083648 (Pubitemid 351892617)
18. Letsch A., Scheibenbogen C., Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods 2003 31 2 143 149 2-s2.0-0041736627 10.1016/S1046-2023(03)00124-5 (Pubitemid 37075899)
19. Streeck H., Frahm N., Walker B. D., The role of IFN- γ Elispot assay in HIV vaccine research. Nature Protocols 2009 4 4 461 469 2-s2.0-64749112680 10.1038/nprot.2009.7
20. Schmittel A., Keilholz U., Bauer S., Kuhne U., Stevanovic S., Thiel E., Scheibenbogen C., Application of the IFN- γ ELISPOT assay to quantify T cell responses against proteins. Journal of Immunological Methods 2001 247 1-2 17 24 2-s2.0-0035172320 10.1016/S0022-1759(00)00305-7 (Pubitemid 32057040)
21. Monaco J. J., Pathways for the processing and presentation of antigens to T cells. Journal of Leukocyte Biology 1995 57 4 543 547 2-s2.0-0028901108
22. Kiecker F., Streitz M., Ay B., Cherepnev G., Volk H.-D., Volkmer-Engert R., Kern F., Analysis of antigen-specific T-cell responses with synthetic peptides-what kind of peptide for which purpose? Human Immunology 2004 65 5 523 536 2-s2.0-2542438553 10.1016/j.humimm.2004.02.017 (Pubitemid 38686777)
23. Draenert R., Altfeld M., Brander C., Basgoz N., Corcoran C., Wurcel A. G., Stone D. R., Kalams S. A., Trocha A., Addo M. M., Goulder P. J. R., Walker B. D., Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. Journal of Immunological Methods 2003 275 1-2 19 29 2-s2.0-0037377309 10.1016/S0022-1759(02)00541-0 (Pubitemid 36351539)
24. Russell N. D., Hudgens M. G., Ha R., Havenar-Daughton C., McElrath M. J., Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. Journal of Infectious Diseases 2003 187 2 226 242 2-s2.0-0037439309 10.1086/367702 (Pubitemid 36132636)
25. + T-cell responses in acute hepatitis C virus infection and early therapy. Journal of Virology 2005 79 20 12979 12988 2-s2.0-26444435730 10.1128/JVI.79.20.12979-12988.2005 (Pubitemid 41433217)
26. Addo M. M., Yu X. G., Rathod A., Cohen D., Eldridge R. L., Strick D., Johnston M. N., Corcoran C., Wurcel A. G., Fitzpatrick C. A., Feeney M. E., Rodriguez W. R., Basgoz N., Draenert R., Stone D. R., Brander C., Goulder P. J. R., Rosenberg E. S., Altfeld M., Walker B. D., Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. Journal of Virology 2003 77 3 2081 2092 2-s2.0-0037302428 10.1128/JVI.77.3.2081-2092.2003 (Pubitemid 36110021)
27. + T cells in chronic HIV infection. AIDS Research and Human Retroviruses 2006 22 10 1007 1013 2-s2.0-33846205655 10.1089/aid.2006.22.1007 (Pubitemid 46100686)
28. + T cells. Journal of Immunological Methods 2009 342 1-2 33 48 2-s2.0-59749101382 10.1016/j.jim.2008. 11.020
29. Currier J. R., Kuta E. G., Turk E., Earhart L. B., Loomis-Price L., Janetzki S., Ferrari G., Birx D. L., Cox J. H., A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. Journal of Immunological Methods 2002 260 1-2 157 172 2-s2.0-0036469827 10.1016/S0022-1759(01)00535-X (Pubitemid 34132882)
30. Dubey S., Clair J., Fu T.-M., Guan L., Long R., Mogg R., Anderson K., Collins K. B., Gaunt C., Fernandez V. R., Zhu L., Kierstead L., Thaler S., Gupta S. B., Straus W., Mehrotra D., Tobery T. W., Casimiro D. R., Shiver J. W., Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. Journal of Acquired Immune Deficiency Syndromes 2007 45 1 20 27 2-s2.0-34247635041 10.1097/QAI.0b013e3180377b5b (Pubitemid 46684439)
31. Reyes-Sandoval A., Pearson F. E., Todryk S., Ewer K., Potency assays for novel T-cell-inducing vaccines against malaria. Current Opinion in Molecular Therapeutics 2009 11 1 72 80 2-s2.0-58849088086
32. Keating S. M., Bejon P., Berthoud T., Vuola J. M., Todryk S., Webster D. P., Dunachie S. J., Moorthy V. S., McConkey S. J., Gilbert S. C., Hill A. V. S., Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. Journal of Immunology 2005 175 9 5675 5680 2-s2.0-27144489392 (Pubitemid 41508049)
33. Calarota S. A., Foli A., Maserati R., Baldanti F., Paolucci S., Young M. A., Tsoukas C. M., Lisziewicz J., Lori F., HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. Journal of Immunology 2008 180 9 5907 5915 2-s2.0-44449118581
34. Calarota S. A., Chiesa A., Zelini P., Comolli G., Minoli L., Baldanti F., Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay. Immunology 2013 139 4 533 544
35. Goonetilleke N., Moore S., Dally L., Winstone N., Cebere I., Mahmoud A., Pinheiro S., Gillespie G., Brown D., Loach V., Roberts J., Guimaraes-Walker A., Hayes P., Loughran K., Smith C., De Bont J., Verlinde C., Vooijs D., Schmidt C., Boaz M., Gilmour J., Fast P., Dorrell L., Hanke T., McMichael A. J., Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8+ T-cell epitopes. Journal of Virology 2006 80 10 4717 4728 2-s2.0-33646454992 10.1128/JVI.80.10.4717-4728.2006
36. Campion S., Cohen M. S., McMichael A. J., Galvin S., Goonetilleke N., Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays. European Journal of Immunology 2011 41 1 255 257 2-s2.0-78650331655 10.1002/eji.201040296
37. + T cells after clearance of hepatitis C virus. Journal of Immunology 2002 169 4 2210 2214 2-s2.0-0037103142 (Pubitemid 34857690)
38. Pinder M., Reece W. H. H., Plebanski M., Akinwunmi P., Flanagan K. L., Lee E. A. M., Doherty T., Milligan P., Jaye A., Tornieporth N., Ballou R., Mcadam K. P. M. J., Cohen J., Hill A. V. S., Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clinical and Experimental Immunology 2004 135 2 286 293 2-s2.0-10744225844 10.1111/j.1365-2249.2004.02371.x (Pubitemid 38177969)
39. + T cells. Journal of Immunological Methods 2010 353 1-2 8 19 2-s2.0-77649275176 10.1016/j.jim.2009. 11.006
40. Todryk S. M., Pathan A. A., Keating S., Porter D. W., Berthoud T., Thompson F., Klenerman P., Hill A. V. S., The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. Immunology 2009 128 1 83 91 2-s2.0-68249121371 10.1111/j.1365-2567.2009.03073.x
41. + memory T-cell response. Current HIV Research 2009 7 3 302 310 2-s2.0-67649126332 10.2174/157016209788347930
42. + T cell responses maintain highly functional, broadly directed central memory responses. Journal of Virology 2012 86 12 6959 6969
43. Wherry E. J., Teichgräber V., Becker T. C., Masopust D., Kaech S. M., Antia R., von Andrian U. H., Ahmed R., Lineage relationship and protective immunity of memory CD8T cell subsets. Nature Immunology 2003 4 3 225 234 2-s2.0-0037340417 10.1038/ni889 (Pubitemid 36322131)
44. + T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nature Medicine 2004 10 4 406 410 2-s2.0-11144353591 10.1038/nm1009 (Pubitemid 38508520)
45. + T cells and antiviral protection. Journal of Immunology 2005 175 7 4677 4685 2-s2.0-25444499685 (Pubitemid 41362009)
46. + T effector memory cells protect against liver-stage malaria. Journal of Immunology 2011 187 3 1347 1357 2-s2.0-80051646256 10.4049/jimmunol.1100302
47. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006 312 5779 1530 1533 2-s2.0-33744990609 10.1126/science.1124226 (Pubitemid 43865893)
48. + central memory T cells in protection from simian AIDS. Journal of Immunology 2005 175 6 3502 3507 2-s2.0-24744445172 (Pubitemid 41292007)
49. Hansen S. G., Ford J. C., Lewis M. S., Ventura A. B., Hughes C. M., Coyne-Johnson L., Whizin N., Oswald K., Shoemaker R., Swanson T., Legasse A. W., Chiuchiolo M. J., Parks C. L., Axthelm M. K., Nelson J. A., Jarvis M. A., Piatak M. Jr., Lifson J. D., Picker L. J., Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011 473 7348 523 527 2-s2.0-79957618772 10.1038/nature10003
50. Yang S.-H., Lee C.-G., Park S.-H., Im S.-J., Kim Y.-M., Son J.-M., Wang J.-S., Yoon S.-K., Song M.-K., Ambrozaitis A., Kharchenko N., Yun Y.-D., Kim C.-M., Kim C.-Y., Lee S.-H., Kim B.-M., Kim W.-B., Sung Y.-C., Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Therapy 2006 13 14 1110 1117 2-s2.0-33745753413 10.1038/sj.gt.3302751
51. + memory T cells correlate with a favorable outcome of tuberculosis. Journal of Infectious Diseases 2006 194 7 984 992 2-s2.0-33749027771 10.1086/507427 (Pubitemid 44454084)
52. Winstone N., Guimarães-Walker A., Roberts J., Brown D., Loach V., Goonetilleke N., Hanke T., McMichael A. J., Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN- γ ELISPOT assay. European Journal of Immunology 2009 39 4 975 985 2-s2.0-65449172097 10.1002/eji.200839167
53. Lisziewicz J., Bakare N., Calarota S. A., Bánhegyi D., Szlávik J., Ujhelyi E., Toke E. R., Molnár L., Lisziewicz Z., Autran B., Lori F., Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals. PLoS ONE 2012 7 5 e35416